Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

Launched by UNIVERSITY OF UTAH · Mar 1, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how the blood flow in the brains of unborn babies with congenital heart disease (CHD) may affect their development after birth. Researchers want to understand if abnormal blood flow patterns can lead to delays in how babies grow and develop, and how this might be influenced by factors like the type of heart condition, the mother’s health, and other social factors. By examining a diverse group of pregnant women, the study aims to gather important information that could improve care for these babies.

To participate in this trial, pregnant women must be at least 18 years old and have a single baby (not twins or more) that is suspected to have a congenital heart issue, which might require surgery within the first month after birth. Women who have known genetic disorders in their baby or other serious health issues are not eligible. Participants will be approached during their routine visits to a fetal cardiology clinic, and they can expect to contribute to research that may help future families facing similar challenges.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pregnant women 18 years of age and over with a singleton fetus with known or suspected congenital heart disease anticipated to need intervention or surgery within 30 days of birth.
• Exclusion Criteria:
• • Known fetal chromosomal or genetic abnormalities
• • Multiple gestation pregnancy
• • Fetal extra-cardiac anomalies